Starboard Chief Executive Jeff Smith said that Kenvue, the Tylenol-maker spun out from Johnson & Johnson, should drill down on fixing its underperforming skin health and beauty segment, which he ...
Starboard Value, an activist investor, has reportedly acquired a substantial stake in Kenvue Inc KVUE, the company behind popular consumer products like Tylenol and Listerine. Despite having some ...
Some results have been hidden because they may be inaccessible to you